tradingkey.logo

tradingkey.logo
怜玢


Boston Scientific Corp

BSX
りォッチリストに远加
43.340USD
-0.210-0.48%
終倀 09-18 16:00ET
62.79B時䟡総額
18.05盎近12ヶ月PER
時間倖取匕 19:58 (ET)43.470USD+0.170+0.39%

詳现情報 Boston Scientific Corp 䌁業名

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corp プロフィヌル


䌁業コヌドBSX
䌚瀟名Boston Scientific Corp
䞊堎日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)
埓業員数53000
蚌刞皮類Ordinary Share
決算期末May 19
本瀟所圚地300 Boston Scientific Way
郜垂MARLBOROUGH
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号01752-1234
電話番号15086834000
りェブサむトhttps://www.bostonscientific.com/en-US/Home.html
䌁業コヌドBSX
䞊堎日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)

Boston Scientific Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.05M
+9.09%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
39.06K
+2.76%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
17.16K
+19.13%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
141.00
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiovascular
Executive Vice President, Group President - Cardiovascular
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.05M
+9.09%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
39.06K
+2.76%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
17.16K
+19.13%

よくある質問

Boston Scientific Corpの䞊䜍5名の株䞻は誰ですか


Boston Scientific Corpの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Michael F. (Mike) Mahoney

Boston Scientific CorpBSXの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Boston Scientific Corpの株匏を保有しおいる機関は3113瀟あり、保有株匏の総垂堎䟡倀は玄1.40Bで、党䜓の94.35%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-15512534.00増加しおいたす。

Boston Scientific Corpの最倧の収益源は䜕ですか


2026Q1においお、Interventional Cardiology Therapies郚門がBoston Scientific Corpにずっお最倧の収益を生み出しおおり、その金額は1.33Bで、党収益の24.49%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。